Date Bioengineering Technology Co., Ltd. announced that it will receive CNY 40,000,000 in a equity round of funding on June 7, 2024. The transaction will include participation from new investor Daan Gene Co., Ltd. for CNY 40,000,000, to retain the majority stake in the company. This has been approved in the 4th extraordinary meeting in 2024 of the 8th board of directors of Daan Gene Co., Ltd. The registered capital of the company will increase from CNY 30,000,000 to CNY 70,000,000.